Skip to main content

Complications

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Huadong Medicine
Huadong MedicineChina - Hangzhou
1 program
Laryngeal mask airway(LMA)N/A
Integrated Biosciences
Integrated BiosciencesCA - San Carlos
1 program
Laryngeal mask airway(LMA)N/A1 trial
Active Trials
NCT02240901Completed2,900Est. Apr 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Integrated BiosciencesLaryngeal mask airway(LMA)

Clinical Trials (1)

Total enrollment: 2,900 patients across 1 trials

NCT02240901Integrated BiosciencesLaryngeal mask airway(LMA)

A Multi-center Randomized Clinical Trial About Using LMA or ETI in Elderly Patients

Start: Aug 2016Est. completion: Apr 20202,900 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.